Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

Media Advisory: Terumo BCT at AABB 2016


19 October 2016

MEDIA ADVISORY: The field of healthcare is rapidly changing and hospitals and blood centers alike are under pressure to consistently deliver safe, effective care to patients worldwide. At this year’s AABB 2016 meeting, Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, will exhibit advanced technologies that address these challenges.

What: Terumo BCT will exhibit apheresis collection and blood processing technologies at the annual AABB 2016 Meeting, a premier event targeting blood center and hospital professionals interested in advancing transfusion and cell therapy.

When: 22 to 25 October 2016

AABB 2016
Orange County Convention Center
Orlando, FL
Terumo BCT Booth #937–West Hall E and F

As a key meeting sponsor and global leader in this area, Terumo BCT will participate in CME sessions, host a symposium and demonstrate its technologies at AABB 2016. Innovations on display in the booth #937 include:

  • Trima Accel® Automated Blood Collection System–The world’s leading apheresis collection device and the only system on the market today that can collect any transfusable component, in any combination, helping blood centers better meet the demand for blood in their communities. The device can be used for in-center collections or on mobile drives and is supported by a range of innovative business intelligence and operational software that helps drive efficiencies and quality.
  • Spectra Optia® Apheresis System–The industry's next-generation therapeutic apheresis and cell collection platform designed to help operators spend more time focusing on patient care.
  • Terumo BCT Suite of Software Solutions–Innovative technologies that help customers harness the power of connectivity and real-time data, providing visibility into a blood center’s collection and processing procedures.

Terumo BCT is an exclusive authorized distributor of B Medical Systems biomedical refrigeration products in the United States and Canada. Please visit B Medical Systems at booth #1044 for product demonstrations.

Other Terumo BCT activities taking place throughout the course of the meeting are as follows:

1:00 p.m.
Room W230 A/B
Orange County Convention
Pre-Conference Workshop:
(HEMO) Hemovigilance
Workshop: Learn How
Hemovigilance is Practiced in
the U.S. and How Hospitals
Can Participate
Palani Palaniappan
Executive Vice President,
Innovation & Development
Terumo BCT
“Safety Innovations and
Hemovigilance: Broad
Perspectives on Enabling
7:00 a.m.
Room W240
Orange County Convention
Breakfast Symposium:
Bringing Value to Your Blood
Center: The Potential of
Apheresis Therapies
Richard Smith
Global Clinical Scientist,
Terumo BCT
“Apheresis Optimization for
Immunotherapy Collections”

Ross Fasano, MD
Assistant Professor,
Pathology & Laboratory
Medicine, Emory University
School of Medicine
“Value of Red Blood Cell
Exchange for Sickle Cell
Disease Patients and the
Impact to Blood Centers”

Heather Pidcoke, MD, PhD
Director, Global Clinical
Safety & PRT Scientific
Affairs, Terumo BCT
“Update on Pathogen
Reduction Activities”

About Terumo BCT
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.

Media Contact
Corporate Communications
Phone: +1.303.205.2599
Contact Us


{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{$index+1}}. {{s.label}}